These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 15997346)

  • 1. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.
    Volkmer M; Ouyang F; Deger F; Ernst S; Goya M; Bänsch D; Berodt K; Kuck KH; Antz M
    Europace; 2006 Nov; 8(11):968-76. PubMed ID: 17043071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
    Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Bogun F; Morady F
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1227-30. PubMed ID: 18691235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis.
    Maccabelli G; Tsiachris D; Silberbauer J; Esposito A; Bisceglia C; Baratto F; Colantoni C; Trevisi N; Palmisano A; Vergara P; De Cobelli F; Del Maschio A; Della Bella P
    Europace; 2014 Sep; 16(9):1363-72. PubMed ID: 24558183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
    Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy: validation of voltage mapping criteria for substrate modification by myocardial viability assessment using FDG PET.
    Kettering K; Weig HJ; Reimold M; Schwegler AC; Busch M; Laszlo R; Gawaz M; Schreieck J
    Clin Res Cardiol; 2010 Nov; 99(11):753-60. PubMed ID: 20532538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial.
    Skoda J; Arya A; Garcia F; Gerstenfeld E; Marchlinski F; Hindricks G; Miller J; Petru J; Sediva L; Sha Q; Janotka M; Chovanec M; Waldauf P; Neuzil P; Reddy VY
    J Cardiovasc Electrophysiol; 2016 Mar; 27 Suppl 1():S29-37. PubMed ID: 26969220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
    Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias.
    Schreieck J; Zrenner B; Deisenhofer I; Schmitt C
    Heart Rhythm; 2005 Jan; 2(1):10-4. PubMed ID: 15851257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
    Tung R; Josephson ME; Reddy V; Reynolds MR;
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.
    Tanner H; Hindricks G; Volkmer M; Furniss S; Kühlkamp V; Lacroix D; DE Chillou C; Almendral J; Caponi D; Kuck KH; Kottkamp H
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):47-53. PubMed ID: 19656251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population.
    Di Biase L; Tung R; Szili-Torok T; Burkhardt JD; Weiss P; Tavernier R; Berman AE; Wissner E; Spear W; Chen X; Neužil P; Skoda J; Lakkireddy D; Schwagten B; Lock K; Natale A;
    J Interv Card Electrophysiol; 2017 Apr; 48(3):237-245. PubMed ID: 28064433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a limited linear ablation of post-myocardial infarction ventricular tachycardia using a standardized approach based on sinus rhythm mapping.
    Deneke T; Lawo T; Grewe PH; Calcum B; Rausse R; Bösche L; Shin DI; Zarse M; Horlitz M; Mügge A; Lemke B
    Am J Cardiol; 2010 May; 105(9):1235-9. PubMed ID: 20403472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refinement of CARTO-guided substrate modification in patients with ventricular tachycardia after myocardial infarction.
    Li YG; Wang QS; Grönefeld G; Israel C; Lu SB; Shao Y; Ehrlich JR; Hohnloser SH
    Chin Med J (Engl); 2008 Jan; 121(2):122-7. PubMed ID: 18272037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.